D-1234-2014 Class I Terminated

Recalled by Hospira, Inc. — Lake Forest, IL

FDA drug recall D-1234-2014 was initiated by Hospira, Inc. on Sep 16, 2013 and is designated Class I. Reason for recall: Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 374,500 vials.

Recall Details

Product Type
Drugs
Report Date
Apr 23, 2014
Initiation Date
Sep 16, 2013
Termination Date
Nov 4, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
374,500 vials

Product Description

1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.

Reason for Recall

Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.

Distribution Pattern

Nationwide

Code Information

Lot #25090DK; Exp 01/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1234-2014
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.